Agnieszka Pawlos

Lodz, LD 91347, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia.

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia.

Journal: International journal of molecular sciences

Published: September 10, 2025

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia.

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia.

Journal: Journal of cellular and molecular medicine

Published: August 04, 2025

SGLT2 inhibitors attenuate cholesterol accumulation in Human Aortic Smooth Muscle Cells.

SGLT2 inhibitors attenuate cholesterol accumulation in Human Aortic Smooth Muscle Cells.

Journal: Advances in medical sciences

Published: June 30, 2025

Changes in lipoprotein(a) concentrations in patients with acute coronary syndrome.

Changes in lipoprotein(a) concentrations in patients with acute coronary syndrome.

Journal: Polish archives of internal medicine

Published: March 04, 2025

Emerging therapies for refractory hypercholesterolemia: a narrative review.

Emerging therapies for refractory hypercholesterolemia: a narrative review.

Journal: Future cardiology

Published: July 10, 2024

Lipoprotein(a) levels may temporarily increase during COVID-19: a pilot study.

Lipoprotein(a) levels may temporarily increase during COVID-19: a pilot study.

Journal: Polish archives of internal medicine

Published: March 20, 2024

Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia.

Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia.

Journal: Scientific reports

Published: December 15, 2023

OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy.

OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy.

Journal: Journal of cellular and molecular medicine

Published: November 03, 2023

When the same treatment has different response: The role of pharmacogenomics in statin therapy.

When the same treatment has different response: The role of pharmacogenomics in statin therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 17, 2023

Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.

Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.

Journal: Epidemiology and infection

Published: August 09, 2023

SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol.

SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol.

Journal: Molecules (Basel, Switzerland)

Published: November 30, 2022

Relationship between COVID‑19 severity, markers of endothelial impairment, and Simple Covid Risk Index.

Relationship between COVID‑19 severity, markers of endothelial impairment, and Simple Covid Risk Index.

Journal: Polish archives of internal medicine

Published: September 28, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026